![Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS](https://www.pnas.org/cms/10.1073/pnas.1916570117/asset/c03e80f7-e96c-4e06-ae36-52c2c4fe7006/assets/graphic/pnas.1916570117fig01.jpeg)
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS
![Top: Distribution of kappa opioid (7-transmembrane receptor), estrogen,... | Download Scientific Diagram Top: Distribution of kappa opioid (7-transmembrane receptor), estrogen,... | Download Scientific Diagram](https://www.researchgate.net/publication/287122607/figure/fig2/AS:307434192162817@1450309431281/Top-Distribution-of-kappa-opioid-7-transmembrane-receptor-estrogen-and-androgen.png)
Top: Distribution of kappa opioid (7-transmembrane receptor), estrogen,... | Download Scientific Diagram
![Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00213-022-06118-4/MediaObjects/213_2022_6118_Fig2_HTML.png)
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink
![The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006322319313794-gr1.jpg)
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - ScienceDirect
![Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? | Neuropsychopharmacology Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpp.2014.261/MediaObjects/41386_2015_Article_BFnpp2014261_Fig1_HTML.jpg)
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? | Neuropsychopharmacology
![Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/appi.ajp.2018.18020138/asset/images/medium/appi.ajp.2018.18020138f1.gif)
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry
![Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective - Hashimoto - 2019 - Psychiatry and Clinical Neurosciences - Wiley Online Library Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective - Hashimoto - 2019 - Psychiatry and Clinical Neurosciences - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f19b2dee-7120-47b8-b454-e4643e6fde19/pcn12902-fig-0003-m.jpg)
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective - Hashimoto - 2019 - Psychiatry and Clinical Neurosciences - Wiley Online Library
![Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.0c00741/asset/images/medium/cn0c00741_0003.gif)
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
![Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability - ScienceDirect Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006322322018546-gr1.jpg)
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability - ScienceDirect
![Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00213-022-06118-4/MediaObjects/213_2022_6118_Fig3_HTML.png)
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors | SpringerLink
![Life | Free Full-Text | Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review Life | Free Full-Text | Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review](https://pub.mdpi-res.com/life/life-11-01186/article_deploy/html/images/life-11-01186-g001.png?1636248774)
Life | Free Full-Text | Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
![Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep33401/MediaObjects/41598_2016_Article_BFsrep33401_Fig1_HTML.jpg)
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression | Scientific Reports
![Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/appi.ajp.2018.18020138/asset/images/medium/appi.ajp.2018.18020138f2.gif)
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry
![Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.0c00741/asset/images/large/cn0c00741_0001.jpeg)